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Abstract 
Background: Breast cancer risk prediction models are widely used in clinical settings. Although most of the well‑
known models were designed based on data collected from western population, yet they have been utilized for sur‑
veillance purposes in many limited‑resource countries. Given the genetic variations in risk factors that exist between 
different races, we therefore aimed to develop and validate a tool for breast cancer risk assessment among Sudanese 
women.
Methods: Using cross‑sectional design, 153 subjects were eligible to participate in our study. Data were collected 
from the only couple of tertiary centers in Sudan. They underwent multiple logistic regression using purposeful selec‑
tion method to build the model. Various adjustments were made to determine significant predictors. Overall perfor‑
mance, calibration and discrimination were assessed by R2, O/E ratio and c‑statistic, respectively.
Results: SUDAN predictors of breast cancer were: age, menarche, family history, vegetables and fruits weekly serv‑
ings, and type of cereals that traditional cuisine is made of. Both Nagelkerke R2 (0.495) and O/E ratio (0.78) were good. 
c‑statistic expressed the excellent discriminatory power of the model (0.864, p < 0.001, 95% CI 0.81–0.92).
Conclusions: Our findings suggest that SUDAN provides a simple, efficient and well‑calibrated tool to predict and 
classify women’s lifetime risks of developing breast cancer. Input from our model could be deployed to guide utiliza‑
tion of the more advanced screening modalities in resource‑limited settings to maximize cost effectiveness. Conse‑
quently, this might improve the stage at which the diagnosis is usually made.
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Background
Breast cancer (BC) is the world’s most common malig-
nancy with a constantly increasing incidence [1]. Risk 
prediction models assess either: [2] group odds of devel-
oping breast cancer over time as BCRAT (Gail) model, 
or individual risks of inheriting a mutant BRCA1/2like 
BRCAPRO, BOADICEA, and the Myriad II preva-
lence tables [3]. A practical overlap between the two 
objectives is present in some models. For instance, IBIS 
(Cuzick-Tyrer) mainly estimates the risk of breast cancer 
over time; furthermore, readouts of inheriting a mutant 
BRCA-1/2 are there. BRCAPRO serves the two goals 
inversely. Cuzick-Tyrer represents the most accurate pre-
diction tool [2].
Modern empirical models are used mainly in defining 
individual risk to develop breast cancer. Their use is lim-
ited to clinical settings since they require detailed family 
history and genetic analysis for some of them [4]. Apply-
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As group risk prediction models are used in anticipat-
ing breast cancer probability in a wide scale of popula-
tion, they can help in offering benefits-harms weighted 
screening recommendations, managing patients, and 
improving risk reduction strategies. Women with 
20–25% lifetime risk of BC are advised to undergo breast 
MRI according to American Cancer Society guidelines 
[6]. US Preventive Services Task Force guidelines recom-
mend BRCA1/2 mutation testing for women at a high 
risk of CA breast [7]. FDA recommends prophylactic 
tamoxifen for women with 1.67% 5-years risk of BC [8].
Most of the known models represent analysis of data 
retrieved from American and British studies [9]. This is 
not inclusive of other populations’ circumstances and 
may contradict with its generalization over other com-
munities that differ. Moreover, models like Gail and 
Cuzick-Tyrer consider findings of invasive and costly 
interventions as biopsies to improve the overall accuracy. 
Inconsistently, a proven major risk factor, breast density, 
that could be detected by simple, cheap and non-invasive 
mammographic scan is not incorporated in any model 




This is a multicenter, observational, retrospective, cross-
sectional study conducted in breast clinics of Bashaier 
University Hospital (BUH) and Khartoum Center for 
Radiation and Isotopes (RICK), Khartoum, Sudan. Both 
are leading tertiary centers highly specialized in manag-
ing breast conditions among Sudanese and east African 
nationals. From October 2014 to September 2015, all 
eligible patients referred to either of the study facilities 
were considered. Inclusion criteria were: being a Suda-
nese female who had menarche, confirmed diagnosis 
with a standard triple assessment, cases of BC should 
be of primary type, and accepting participation without 
compensation. Uncertain diagnoses, breast metastasis 
from another primary focus, and comparison subjects 
with proliferative tumors were excluded. A total of 153 
patients aged 32–74 years were enrolled for this study.
Variables and outcome
Data were collected using structured data forms. Height 
and weight were measured using stadiometer of 1  mm 
accuracy and calibrated 0.01 kg sensitive medical weight 
scale, respectively. The investigated 34 defined risk 
factors include demographic (age, education, ethnic-
ity, etc.); medical (past history of benign or malignant 
breast disease); family history of BC; reproductive (e.g., 
menarche, age of marriage and birth of the first live child, 
durations of pregnancy and lactation, and menopause); 
pharmacological (either usage of hormonal contraception 
or risk reducing like aspirin, tamoxifen, and raloxifene); 
nutritional (traditional food cereals, meat and animal 
products; vegetables and fruits, and sugar servings); and 
lifestyle risks like physical exercise, smoking and alcohol 
intake.
Statistical analysis
Statistical analysis was performed using the Statistical 
Package for Social Sciences (SPSS), version 23.0 (SPSS, 
Chicago, IL, USA). Categorical variables were reported 
in numbers and percentages (N, %). Whereas, continuous 
variables were expressed as mean ±  standard deviation 
(SD) at 95% confidence interval (CI).
Using SPSS, a dataset of the 153 participants was made. 
2 × 2 contingency and frequency tables for the categori-
cal and numerical variables were created to ensue occu-
pancy of each cell. No empty cell was present. SUDAN 
CA Breast was built according to purposeful selection 
method. All risk factors individually underwent univari-
ate analysis once-at-a-time using simple binary logistic 
regression. Only 13 with significant Wald χ2 at p < 0.25 
were qualified for a second phase analysis using multi-
variate logistic regression. Five variables with p  <  0.05 
were selected as predictors of the initial logit model. 
Parameter estimates of age, menarche, family history, 
and vegetables and fruits, and sorghum and millets were 
changed by 14.78, 8.88, 14.72, 7.67, 18.42, and 10.99%, 
respectively. Such levels exclude confoundings as none 
exceeded the 20% ceiling. Moreover, they changed insig-
nificantly when variables dropped in phase 1 were subse-
quently added to the main effects model. All predictors 
fulfilled the assumptions of normality, absence of multi-
collinearity, and linearity between probability logit and 
age, menarche, and weekly servings of fruits and vegeta-
bles. Overall performance, discrimination and calibration 
of the final model were assessed for using R2, c-statistic, 
and Hosmer–Lemeshow test, respectively.
Ethical concerns
Ethical clearance of the Research Ethics Committee in 
National Academy of Health Sciences was obtained. 
Institutional approvals were also received prior to com-
mencement of the research. Our study strictly fol-
lowed Declaration of Helsinki. Informed consents were 
obtained from all participants after ensuring anonymity.
Results
Demographic and clinical features of participants
A total of 184 patients were referred to our facilities dur-
ing study period. After assessing eligibility, 153 females 
were incorporated in the model (Fig. 1). 63 (41.2%) sub-
jects were diagnosed with the cancer. The median age 
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of our sample was 37.00 (±  14.30) years. It was 46.89 
(±  14.99) years for breast cancer patients and 32.64 
(±  10.41) years for those who did not have the disease. 
Patients who were illiterate were more than those who 
had not BC, 34.92% compared to 17.78%. Low socio-
economic status was invariably predominant among 
respondents (N = 132; 86.27%). 120 (78.43%) of our sam-
ple came from central Sudan, whereas only 4 were from 
eastern states. Almost half of our African subjects had 
breast cancer (N = 26; 48.15%), compared to 37 (37.37%) 
of the remaining ethnicities.
Interestingly, a positive past history of breast diseases 
was seen in one-third of the comparison group, close 
to the 26.98% BC patients. Twenty (31.75%) of can-
cer patients had a familial pattern of the disease which 
existed in 12 (13.33%) of the counter group. Menarche 
of BC patients was significantly earlier than others mean, 
14.77  ±  1.70 compared to 14.05  ±  1.92 (p  =  0.016). 
Conversely, menopause of the former at 48.09 (±  5.49) 
years was insignificantly delayed from counterparts’ 
mean (M = 26.11 ± 2.57, p = 0.312). Married BC patients 
were 56 (88.89%), making the figure eightfold the number 
of singles (7, 11.11%). They experience marriage at 20.73 
(± 6.98) years, one and half year prior to unaffected par-
ticipants 22.14 (±  6.21, p =  0.245) years. Most partici-
pants with cancer have given birth to single or multiple 
offspring (52; 82.54%) at the age of 21.25 (± 6.28) years.
Contraception was used by only 18 (28.57%) patients, 
14 of them received contraceptive pills. This was even 
less than those used contraception and do not gain the 
disease (28; 31.11%). Regular use of the prophylactic ace-
tylsalicylic acid was used by only 4 (6.35%) and 5 (5.56%) 
subjects with and without malignancy. Tamoxifen and 
raloxifene were taken by none.
Two of the four nutritional patterns that have been 





Fig. 1 Likelihood measures of SUDAN. 1 ROC curve showing the AUC c‑statistic. 2 Scatter plots of continuous data. 2a age in a polynomial rela‑
tionship; 2b and 2c menarche and weekly serving of vegetables and fruits. Showing wide scattering, weak relation and negative direction of the 
polynomial regression line
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and fruits and vegetables servings. Sudanese frequently 
eat their traditional meals that are rich in starchy ingre-
dients. Types of cereals, meals are made of, were inves-
tigated. Among the 23 (15.03%) subjects who consume 
millet, 69.57% harbor BC. Most of our samples eat veg-
etables and fruits throughout the week with an indis-
criminate mean between healthy and ill individuals, 
6.62 (±  0.958) and 6.79 (±  0.679) servings per week, 
respectively.
Uni‑ and multivariate analysis
Table 1 contains the results of the univariate analysis of 
the 34 known risk factors resulted in only 13 significant 
at p < 0.25. When incorporated into a single multivariate 
logistic regression, the 5 with p < 0.05 were the predictors 
(Table 2).
A logistic regression was performed to assess the 
effects of age, menarche, family history, vegetables and 
fruits weekly servings, and type of cereals that traditional 
cuisine is made of in causing BC. The logistic regres-
sion model was statistically significant (χ2  =  70.027, 
p  <  0.001). SUDAN had successfully classified 49.5% of 
variance existed between the two groups (Nagelkerke 
R2 =  0.495). Age has a significant positive relation with 
breast cancer. An increase in age by 1 year increases the 
odds of BC by 1.103 compared to the preceding year. 
Conversely, menarche is inversely related to the disease 
with each year of delay that minimizes lifetime risks by 
Table 1 Main effects model containing significant factors (p < 0.25) underwent univariate analysis
Factors Mean (± SD)/N (%) β S.E. p value OR 95% CI
Demographic risks
 Age (years) 38.5 (± 14.3) 0.093 0.018 0.000 1.098 1.06–1.14
 Educational level
  Illiterate 38 (24.8%) 0.909 0.382 0.017 2.482 1.17–5.25
  Literate 115 (75.2%) (Reference)
 Occupational status
  Unemployed 111 (72.5%) 1.073 0.409 0.009 2.924 1.31–6.52
  Employed 42 (27.5%) (Reference)
 Ethnicity
  African 54 (35.3%) 0.442 0.343 0.197 1.556 0.80–3.05
  Non‑African 99 (64.7%) (Reference)
Family
 Family history of BC
  NA 121 (79.1%) (Reference)
  YA 32 (20.9%) 1.106 0.412 0.007 3.023 1.35–6.77
Reproductive
 Menarche (years) 14.5 (± 1.8) − 0.227 0.096 0.018 0.797 0.66–0.96
 Marital status
  Single 33 (21.6%) (Reference)
  Married/have married 120 (78.4%) 1.179 0.463 0.011 3.250 1.31–8.06
 Birth history
  Nulliparous 43 (28.1%) (Reference)
  Parous 110 (71.9%) 0.959 0.398 0.016 2.608 1.20–5.69
Nutritional
 Traditional food cereals (servings/week)
  Wheat 107 (69.9%) (Reference)
  Sorghum/Milo 23 (15.0%) 1.249 0.476 0.009 3.488
  Millet 23 (15.0%) 1.634 0.499 0.001 5.126
 Vegetables & fruits (servings/week) 5.4 (± 2.2) − 0.212 0.078 0.007 0.809
Sleep
 Nocturnal sleeping (h) 7.19 (± 1.7) − 0.143 0.101 0.157 0.867 0.71–1.06
Measurements
 Weight (kg) 66.0 (± 16.1) 0.014 0.010 0.188 1.014 0.99–1.03
 Body mass index (kg/m2) 24.6 (± 5.6) 0.041 0.030 0.166 1.042 0.98–1.11
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0.273. Positive family history of BC triples likelihood of 
developing malignancy during lifetime. Increasing the 
number of weekly servings of vegetables and fruits by 
a single digit reduces the risk of BC by 0.232. Classical 
Sudanese gastronomy is based on three main cereals. 
Using wheat as a reference point, subjects who depend on 
sorghum had a threefold increase in their odds of breast 
cancer. Even more, millet tops risk up by five times.
Model performance
SUDAN was assessed in terms of overall performance, 
discrimination and calibration using R2, c-statistic, and 
Hosmer–Lemeshow Goodness of fit (GOF) test, respec-
tively. With a Nagelkerke R2 of 0.495, the model is capable 
of justifying almost half of the variance in breast cancer. 
Discriminatory power measured by c-statistic of AUC 
equals to 0.864 (p < 0.001, 95% CI 0.81–0.92). Hosmer–
Lemeshow GOF test showed an insignificant difference 
between observed and predicted probabilities making the 
model well calibrated (χ2 = 7.159, 8 df, p = 0.520). Inter-
nal validation of the model revealed an O/E ratio of 0.78.
Discussion
To the best of our knowledge, SUDAN is the pioneering 
tool to assess risk of developing BC in Sudan, Africa, and 
Middle East. Moreover, it is the first ever of its kind been 
built using purposeful selection technique. It represents a 
multivariate logistic regression analysis of data collected 
in a cross-sectional study, which specified five predictors 
of breast cancer: age, menarche, family history, vegeta-
bles and fruits weekly servings, and type of cereals used. 
The former three are shared by Gail and Cuzick-Tyrer 
models. Claus, BRCAPRO, and BOADICEA have the 
same triad except menarche [10]. None of our nutritional 
factors was a predictor in any of the previous models. 
However, the relationship between nutrition and BC 
has been established in many studies. Kamath et al. [11] 
stated that strict vegetarians are three times less likely to 
have the disease (OR 2.80, 95% CI 1.15–6.81). Another 
study found a significant association between starchy 
food, like cereals, and certain categories of BC, ER-ve 
subtypes [12]. By increasing weekly servings of vegetables 
and fruits and replacing millet and sorghum by wheat, 
risks get minimized in favor of primary prevention.
The two most important predisposing factors for BC 
are increasing age and positive family history [13]. The 
presence of menarche among predictors can be expressed 
molecularly. Association between reproductive risk fac-
tors of BC, including menarche, and ER+ tumors, has 
been previously described [14, 15]. Fadl Elmoula et  al. 
[16] reported a similar prevalence of ER+ among Suda-
nese and western women. On the contrary, since ER+ 
status is much less among Asians [17–19], risk prediction 
model for Thai appeared without menarche. Exception-
ally, as receptor status of Koreans and western women 
are comparable [20], four out of KoBCRAT predictors 
were reproductive risks.
With an OR of 3.13, familial factors appear to play a key 
role in causing breast cancer. Genetically, breast cancer 
has autosomal dominant inheritance, predominantly for 
BRCA1/2 genes. Elnour et  al. [21] found that BRCA1/2 
mutations to be common in Sudan. Awadelkarim et  al. 
[22] reached similar conclusions; moreover, they high-
lighted that 28% of their patients’ germline mutations to 
be novel. Furthermore, 24.3% of identified point muta-
tions studied by Biunno et al. [23] poses unknown clinical 
significance, and 42.4% of them are unique to Africa.
The significance of family history and consequently 
BRCA1/2 predisposition may be attributed to the wide-
spread consanguineous marriages in Sudan. The nation 
has the highest global rate of matrimonies involving cou-
ples who are first degree cousins (45%) [24]. This was 
even higher in Saha et al.’s [25] study (49.5%), with addi-
tional 13% of participants married to relative husbands of 
further degrees.
SUDAN has a concordance index of 0.864, which is 
described as excellent [26]. This was much higher than 
the reported c-statistic of Gail Model in a study among 
western women(meta-analyzed c-statistic = 0.63; 95% CI 
0.59–0.67) [27]. KoBCRAT has a c-statistics of 0.63 for 
< 50 year women and 0.65 for others [28]. This high dis-
criminatory accuracy qualifies our model to meet screen-
ing purposes and define population at high-risk, which 
better redirect our limited resources [29].
SUDAN model O/E ratio of 0.78 makes it second to 
Cuzick-Tyrer only (0.81; 95% CI 0.62–1.08), accord-
ing to Amir et  al. [30]. Corresponding values for Claus, 
BRCAPRO, and Gail were 0.56 (95% CI 0.43–0.75), 
0.49 (95% CI 0.37–0.65), and 0.48 (95% CI 0.37–0.64), 
respectively. Since our overall O/E ratios of less than 
Table 2 Five predictors of  SUDAN CA Breast with  their 
parameter estimates
Predictors Β S.E. p‑value OR 95% CI
Age (years) 0.098 0.021 0.000 1.103 1.057–1.150
Menarche(years) − 0.318 0.124 0.010 0.727 0.571–0.926
Family history of BC
 NA 0.000 1 (Ref )
 YA 1.141 0.504 0.024 3.130 1.166–8.406
Vegetables & fruits 
(servings/week)
− 0.265 0.112 0.018 0.767 0.616–0.956
Traditional food cereals (servings/week)
 Wheat 0.000 1 (Ref )
 Sorghum/Milo 1.098 0.599 0.067 2.997 0.927–9.688
 Millet 1.676 0.659 0.011 5.345 1.468–19.463
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1.00, subjects that really had the disease were less than 
expected. This raises false positives; however, it is accept-
able as it increases catchment and, consequently, screen-
ing purposes which represent the principle aim of our 
model. O/E ratio will improve with an increase in the 
sample size as it better assesses predictors.
Limitations
This study has some limitations which are addressed 
here. Firstly, since the cross-sectional design was used, 
causality relationship for significant variables could not 
be proven. Secondly, the model offers group predictions 
in the form of OR. Individual relative risks (RR) could 
not be calculated as the study design was not longitudi-
nal follow-up. Thirdly, although regression sample size is 
an issue that is not agreed upon, however, it is relatively 
small though fulfilling rule of ten.
Conclusion and recommendations
Breast cancer constitutes a real problem in Sudan. Early 
onset, late presentation, and limited resources are the 
characteristics unique to our national context of BC. This 
triad could be better dealt with by inventing a prediction 
tool. SUDAN considers risk factors in women of different 
ages and ranks them accordingly. This makes them aware 
of their odds and subsequently improves early detection. 
Cost effectiveness will be enhanced further by recom-
mending screening measures for high-risk individuals. 
Our model showed good calibration and excellent dis-
criminatory power.
Factors influence the role of family history and the 
prevalent BRCA1/2 predisposition are results of the 
high rates of consanguineous marriage. However, further 
genetic studies on the penetrance of BRCA1/2 and pre-
disposition to other mutant genes should be considered. 
Utilization of purposeful selection method is advisable 
particularly when sample size used is relatively small. The 
authors support previous recommendations on establish-
ing a national registry for cancer in Sudan. This will offer 
a potential data source for externally validating this model 
and developing it further to better fit Sudanese women.
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